Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
|Articles|January 15, 2020
Latest in People and Business News
The latest industry happenings, all in one place.
Advertisement
People news
Signant Health announced that it has appointed Paul Drake, PhD, as Chief Compliance and Security Officer.
Clinical SCORE announced the appointment of Samantha Daugherty to the position of Vice President, Director of Operations.
Adaptive Clinical Systems has hired Temitope Keyes as VP of Business Development.
Crosstree has announced that Gordon Ryerson is returning to the firm to launch the company’s newest service: Strategic Value Creation.
Raremark announced additions to its executive team. Neil Rotherham, Tim Davis, and Jeremy Edwards have been appointed Chairman, Chief Executive
Officer and Chief Commercial Officer, respectively.
Business news
Karadeniz Technical University Farabi Hospital has joined Clinerion’s Patient Network Explorer platform.
Trialbee announced that it has experienced triple year over year growth.
AiCure announced their revenue has grownby over 65% from the prior year.
Recognition
ERT announced an ERT record: 75% of the compounds approved by U.S. FDA in 2019 were developed using one or more of ERT’s eClinical solutions during the drug development process.
Advertisement
Related to this article
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
3
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
4
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
5